Loading…
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma
Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in pa...
Saved in:
Published in: | British journal of cancer 2020-05, Vol.122 (11), p.1686-1694 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93 |
---|---|
cites | cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93 |
container_end_page | 1694 |
container_issue | 11 |
container_start_page | 1686 |
container_title | British journal of cancer |
container_volume | 122 |
creator | Togo, Maria Yokobori, Takehiko Shimizu, Kimihiro Handa, Tadashi Kaira, Kyoichi Sano, Takaaki Tsukagoshi, Mariko Higuchi, Tetsuya Yokoo, Satoshi Shirabe, Ken Oyama, Tetsunari |
description | Background
Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro-
d
-glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors,
18
F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8
+
tumour-infiltrating lymphocytes (TILs) in OSCC.
Methods
We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative
18
F-FDG-uptake, clinicopathological characteristics and prognosis.
Results
Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high
18
F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high
18
F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative
18
F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status.
Conclusions
18
F-FDG-uptake is an independent predictor of cold tumour in OSCC.
18
F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status. |
doi_str_mv | 10.1038/s41416-020-0820-z |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7250916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2406924155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</originalsourceid><addsrcrecordid>eNp1Ul2LEzEUDaK4dfUH-BbwRZCs-ZhMkhdB2u2uUHAf1ueQZjJtlpmkm2QWuv_H_2nKFEXBl1xy7zmHey4HgPcEXxHM5OfckIa0CFOMsKzP8wuwIJxRRCQVL8ECYywQVhRfgDc5P9SvwlK8BheMUiYVUQvwc-XNLsRcvIVPZpgcjD0kco3Wqxt0d30PS4SH5DpvCyx7B8s0xilBP45TcDAXU6YMO9f74Dq4PZ7nZoB3K7Qh0IQOLlfy09xGPvR-KMkUH3ZwOI6HfbTH4jL0AcYTKz9OpiIztG4YoDXJ-hBH8xa86s2Q3btzvQQ_1tf3y1u0-X7zbfl1gywToiBpTUe2LeedY9bZlvAtbWthxHHZNpJw4aQSsqXSWsww6zvJrDKKsdbyXrFL8GXWPUzb0XXWhbrsoA_JjyYddTRe_z0Jfq938UkLyrEibRX4eBZI8XFyuejR55MXE1y1pevZucBK8KZCP_wDfagnCtWepg1uFW0I5xVFZpRNMefk-t_LEKxPIdBzCHQNgT6FQD9XDp05uWLDzqU_yv8n_QJEI7Vk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406924155</pqid></control><display><type>article</type><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</creator><creatorcontrib>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</creatorcontrib><description>Background
Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro-
d
-glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors,
18
F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8
+
tumour-infiltrating lymphocytes (TILs) in OSCC.
Methods
We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative
18
F-FDG-uptake, clinicopathological characteristics and prognosis.
Results
Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high
18
F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high
18
F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative
18
F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status.
Conclusions
18
F-FDG-uptake is an independent predictor of cold tumour in OSCC.
18
F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/s41416-020-0820-z</identifier><identifier>PMID: 32238919</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/327 ; 631/67/580/1884 ; 692/53/2421 ; Apoptosis ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; CD8 antigen ; Cold ; Drug Resistance ; E-cadherin ; Epidemiology ; Glucose transporter ; Hypoxia-inducible factor 1 ; Hypoxia-inducible factor 1a ; Hypoxia-inducible factors ; Immune checkpoint ; Immune status ; Lung cancer ; Lymphocytes ; Medical diagnosis ; Molecular Medicine ; Oncology ; Oral cancer ; Oral squamous cell carcinoma ; PD-1 protein ; PD-L1 protein ; Phenotypes ; Positron emission tomography ; Prognosis ; Squamous cell carcinoma ; Tumors</subject><ispartof>British journal of cancer, 2020-05, Vol.122 (11), p.1686-1694</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</citedby><cites>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250916/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250916/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Togo, Maria</creatorcontrib><creatorcontrib>Yokobori, Takehiko</creatorcontrib><creatorcontrib>Shimizu, Kimihiro</creatorcontrib><creatorcontrib>Handa, Tadashi</creatorcontrib><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Sano, Takaaki</creatorcontrib><creatorcontrib>Tsukagoshi, Mariko</creatorcontrib><creatorcontrib>Higuchi, Tetsuya</creatorcontrib><creatorcontrib>Yokoo, Satoshi</creatorcontrib><creatorcontrib>Shirabe, Ken</creatorcontrib><creatorcontrib>Oyama, Tetsunari</creatorcontrib><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>Background
Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro-
d
-glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors,
18
F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8
+
tumour-infiltrating lymphocytes (TILs) in OSCC.
Methods
We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative
18
F-FDG-uptake, clinicopathological characteristics and prognosis.
Results
Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high
18
F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high
18
F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative
18
F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status.
Conclusions
18
F-FDG-uptake is an independent predictor of cold tumour in OSCC.
18
F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</description><subject>631/67/327</subject><subject>631/67/580/1884</subject><subject>692/53/2421</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>CD8 antigen</subject><subject>Cold</subject><subject>Drug Resistance</subject><subject>E-cadherin</subject><subject>Epidemiology</subject><subject>Glucose transporter</subject><subject>Hypoxia-inducible factor 1</subject><subject>Hypoxia-inducible factor 1a</subject><subject>Hypoxia-inducible factors</subject><subject>Immune checkpoint</subject><subject>Immune status</subject><subject>Lung cancer</subject><subject>Lymphocytes</subject><subject>Medical diagnosis</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Oral cancer</subject><subject>Oral squamous cell carcinoma</subject><subject>PD-1 protein</subject><subject>PD-L1 protein</subject><subject>Phenotypes</subject><subject>Positron emission tomography</subject><subject>Prognosis</subject><subject>Squamous cell carcinoma</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1Ul2LEzEUDaK4dfUH-BbwRZCs-ZhMkhdB2u2uUHAf1ueQZjJtlpmkm2QWuv_H_2nKFEXBl1xy7zmHey4HgPcEXxHM5OfckIa0CFOMsKzP8wuwIJxRRCQVL8ECYywQVhRfgDc5P9SvwlK8BheMUiYVUQvwc-XNLsRcvIVPZpgcjD0kco3Wqxt0d30PS4SH5DpvCyx7B8s0xilBP45TcDAXU6YMO9f74Dq4PZ7nZoB3K7Qh0IQOLlfy09xGPvR-KMkUH3ZwOI6HfbTH4jL0AcYTKz9OpiIztG4YoDXJ-hBH8xa86s2Q3btzvQQ_1tf3y1u0-X7zbfl1gywToiBpTUe2LeedY9bZlvAtbWthxHHZNpJw4aQSsqXSWsww6zvJrDKKsdbyXrFL8GXWPUzb0XXWhbrsoA_JjyYddTRe_z0Jfq938UkLyrEibRX4eBZI8XFyuejR55MXE1y1pevZucBK8KZCP_wDfagnCtWepg1uFW0I5xVFZpRNMefk-t_LEKxPIdBzCHQNgT6FQD9XDp05uWLDzqU_yv8n_QJEI7Vk</recordid><startdate>20200526</startdate><enddate>20200526</enddate><creator>Togo, Maria</creator><creator>Yokobori, Takehiko</creator><creator>Shimizu, Kimihiro</creator><creator>Handa, Tadashi</creator><creator>Kaira, Kyoichi</creator><creator>Sano, Takaaki</creator><creator>Tsukagoshi, Mariko</creator><creator>Higuchi, Tetsuya</creator><creator>Yokoo, Satoshi</creator><creator>Shirabe, Ken</creator><creator>Oyama, Tetsunari</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200526</creationdate><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><author>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/67/327</topic><topic>631/67/580/1884</topic><topic>692/53/2421</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>CD8 antigen</topic><topic>Cold</topic><topic>Drug Resistance</topic><topic>E-cadherin</topic><topic>Epidemiology</topic><topic>Glucose transporter</topic><topic>Hypoxia-inducible factor 1</topic><topic>Hypoxia-inducible factor 1a</topic><topic>Hypoxia-inducible factors</topic><topic>Immune checkpoint</topic><topic>Immune status</topic><topic>Lung cancer</topic><topic>Lymphocytes</topic><topic>Medical diagnosis</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Oral cancer</topic><topic>Oral squamous cell carcinoma</topic><topic>PD-1 protein</topic><topic>PD-L1 protein</topic><topic>Phenotypes</topic><topic>Positron emission tomography</topic><topic>Prognosis</topic><topic>Squamous cell carcinoma</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Togo, Maria</creatorcontrib><creatorcontrib>Yokobori, Takehiko</creatorcontrib><creatorcontrib>Shimizu, Kimihiro</creatorcontrib><creatorcontrib>Handa, Tadashi</creatorcontrib><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Sano, Takaaki</creatorcontrib><creatorcontrib>Tsukagoshi, Mariko</creatorcontrib><creatorcontrib>Higuchi, Tetsuya</creatorcontrib><creatorcontrib>Yokoo, Satoshi</creatorcontrib><creatorcontrib>Shirabe, Ken</creatorcontrib><creatorcontrib>Oyama, Tetsunari</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Togo, Maria</au><au>Yokobori, Takehiko</au><au>Shimizu, Kimihiro</au><au>Handa, Tadashi</au><au>Kaira, Kyoichi</au><au>Sano, Takaaki</au><au>Tsukagoshi, Mariko</au><au>Higuchi, Tetsuya</au><au>Yokoo, Satoshi</au><au>Shirabe, Ken</au><au>Oyama, Tetsunari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><date>2020-05-26</date><risdate>2020</risdate><volume>122</volume><issue>11</issue><spage>1686</spage><epage>1694</epage><pages>1686-1694</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><abstract>Background
Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro-
d
-glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors,
18
F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8
+
tumour-infiltrating lymphocytes (TILs) in OSCC.
Methods
We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative
18
F-FDG-uptake, clinicopathological characteristics and prognosis.
Results
Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high
18
F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high
18
F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative
18
F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status.
Conclusions
18
F-FDG-uptake is an independent predictor of cold tumour in OSCC.
18
F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32238919</pmid><doi>10.1038/s41416-020-0820-z</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British journal of cancer, 2020-05, Vol.122 (11), p.1686-1694 |
issn | 0007-0920 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7250916 |
source | Open Access: PubMed Central; Springer Nature |
subjects | 631/67/327 631/67/580/1884 692/53/2421 Apoptosis Biomedical and Life Sciences Biomedicine Cancer Research CD8 antigen Cold Drug Resistance E-cadherin Epidemiology Glucose transporter Hypoxia-inducible factor 1 Hypoxia-inducible factor 1a Hypoxia-inducible factors Immune checkpoint Immune status Lung cancer Lymphocytes Medical diagnosis Molecular Medicine Oncology Oral cancer Oral squamous cell carcinoma PD-1 protein PD-L1 protein Phenotypes Positron emission tomography Prognosis Squamous cell carcinoma Tumors |
title | Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%2018F-FDG-PET%20to%20predict%20the%20tumour%20immune%20status%20defined%20by%20tumoural%20PD-L1%20and%20CD8+tumour-infiltrating%20lymphocytes%20in%20oral%20squamous%20cell%20carcinoma&rft.jtitle=British%20journal%20of%20cancer&rft.au=Togo,%20Maria&rft.date=2020-05-26&rft.volume=122&rft.issue=11&rft.spage=1686&rft.epage=1694&rft.pages=1686-1694&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/s41416-020-0820-z&rft_dat=%3Cproquest_pubme%3E2406924155%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406924155&rft_id=info:pmid/32238919&rfr_iscdi=true |